EAGLE PHARMACEUTICALS, INC. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2013 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Eagle Pharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2013 to Q2 2023.
  • Eagle Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2023 was $4.19M, a 6.84% decline year-over-year.
  • Eagle Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2023 was $16.5M, a 6.12% decline year-over-year.
  • Eagle Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $16.5M, a 15.9% decline from 2021.
  • Eagle Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $19.6M, a 21% decline from 2020.
  • Eagle Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2020 was $24.8M, a 12.5% increase from 2019.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 $16.5M $4.19M -$308K -6.84% Apr 1, 2023 Jun 30, 2023 10-Q/A 2023-08-09
Q1 2023 $16.8M $4.64M +$344K +8.01% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $16.5M $4.12M -$563K -12% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-23
Q3 2022 $17M $3.54M -$547K -13.4% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $17.6M $4.5M +$219K +5.12% Apr 1, 2022 Jun 30, 2022 10-Q/A 2023-08-09
Q1 2022 $17.3M $4.3M -$2.21M -34% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $19.6M $4.68M -$1.64M -25.9% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-23
Q3 2021 $21.2M $4.08M -$638K -13.5% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $21.8M $4.28M -$1.96M -31.4% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $23.8M $6.51M -$964K -12.9% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 $24.8M $6.32M +$1.14M +22% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-23
Q3 2020 $23.6M $4.72M -$929K -16.4% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $24.5M $6.24M +$859K +16% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $23.7M $7.47M +$1.69M +29.2% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 $22M $5.18M +$613K +13.4% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-08
Q3 2019 $21.4M $5.65M +$1.18M +26.4% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-02
Q2 2019 $20.2M $5.38M +$647K +13.7% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $19.6M $5.78M +$477K +8.99% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 $19.1M $4.57M +$759K +19.9% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-05
Q3 2018 $18.3M $4.47M +$744K +20% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $17.6M $4.74M +$1.04M +28.1% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $16.5M $5.31M +$1.11M +26.5% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q4 2017 $15.4M $3.81M +$1.58M +71% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-02
Q3 2017 $13.8M $3.73M +$1.48M +65.7% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-01
Q2 2017 $12.4M $3.7M +$1.28M +52.8% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 $11.1M $4.19M +$1.32M +46.1% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 $9.77M $2.23M +$1.12M +101% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-28
Q3 2016 $8.65M $2.25M +$901K +66.8% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 $7.75M $2.42M +$1.21M +100% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 $6.54M $2.87M +$2.49M +647% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-08
Q4 2015 $4.05M $1.11M +$825K +290% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-26
Q3 2015 $3.23M $1.35M +$1.13M +502% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 $2.1M $1.21M +$1.05M +637% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 $1.06M $384K +$100K +35.2% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 $956K $284K +$206K +264% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-15
Q3 2014 $750K $224K Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-12
Q2 2014 $164K +$35.7K +27.8% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-11
Q1 2014 $284K +$187K +192% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-15
Q4 2013 $78K Oct 1, 2013 Dec 31, 2013 10-QT 2015-02-17
Q2 2013 $128K Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-11
Q1 2013 $97.2K Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.